Clinical and Histological Characterization of Toxic Keratopathy From Depatuxizumab Mafodotin (ABT-414), an Antibody-Drug Conjugate: [RETRACTED]

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical and Histological Characterization of Toxic Keratopathy From Depatuxizumab Mafodotin (ABT-414), an Antibody-Drug Conjugate: [RETRACTED]'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry